Certified by Founder Lodge
Avoro Capital Advisors
United States - New York
INVESTOR
1 Disclosed Funding Rounds $135,000,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Global life sciences firm focused on investments in biotechnology and specialty therapeutics.
Company | Date | Round | Raised |
---|---|---|---|
Hemab Therapeutics | February, 22 ,2023 | Series B | $135,000,000 |
Vicebio | September, 24 ,2024 | Series B | $100,000,000 |